Conception is a company developing the technology to turn skin cells into viable human eggs.
Conception has raised $20.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2021.
Conception's investors include HOF Capital, Compound, Sam Altman, Jaan Tallinn, For Good Ventures.
Conception is headquartered in Berkeley, United States.
Conception is a company developing the technology to turn skin cells into viable human eggs.
Conception is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Conception — Funding & Investors." VCBacked, November 23, 2021, https://www.vcbacked.co/company/conception. Accessed September 30, 2026.
VCBacked. (2021). Conception — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/conception
{{cite web |title=Conception — Funding & Investors |url=https://www.vcbacked.co/company/conception |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated